Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in RZLT — Rezolute, Inc.

CIK 72971 SAN FRANCISCO, CA
Back to RZLT Full portfolio

Position in RZLT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$353,224
+$269,551 QoQ
Shares Held
67,928
+147.6% QoQ
Ownership
0.071%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#72
of 144 holders
Holding Since
Sep 2021
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RZLT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. RZLT ranks #208 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in RZLT

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $353,224 67,928
2026-03-31 $83,673 27,434
2025-12-31 $211,570 89,649
2025-09-30 $461,877 49,136
2025-06-30 $159,409 35,742
2024-03-31 $655 257
2023-12-31 $233 235
2023-09-30 $294 223
2023-06-30 $451 228
2023-03-31 $420 219
2022-12-31 $447 216
2022-09-30 $526 192
2022-06-30 $639 198
2022-03-31 $243 72
2021-12-31 $339 71
2021-09-30 $209 28